Paul, Weiss advised Roark Capital Management in the final closing of Roark Capital Partners III. The final closing secured commitments bringing the aggregate total to $1.5 billion, which exceeded the initial target of $1.25 billion. The fund will target control equity and equity-related investments in middle-market companies primarily in the United States.

Paul, Weiss advised Iron Point Partners in the final closing of Iron Point Real Estate Partners II. The final closing secured commitments bringing the aggregate total commitments of the fund to $750 million, exceeding the initial target of $450 million. The fund will target real estate investments in the United States.

Paul, Weiss client LNK Partners, LLC held the final closing of its second private equity fund, LNK Partners II, L.P.. This closing brings the fund's total commitments to its target of $400 million. The fund focuses on middle-market retail and consumer portfolio investments.

As reported in DowJones Financial News, PRNewswire and MarketWatch, long-time Paul, Weiss client Oak Hill Advisors, L.P., an independent investment firm specializing in leveraged loans, high yield bonds, structured products, distressed securities and turnaround investments, held the final close for its OHA European Strategic Credit Fund, bringing in $1.35 billion of investor commitments, in excess of the fund's initial $750 million target. The fund focuses on distressed credit investments, primarily in Western Europe.

Paul Weiss advised Oak Hill Investment Management, L.P. in the $1.4 billion sale by Conversus Capital, L.P., a publicly traded portfolio of third party private equity funds, of its portfolio of private equity fund interests and direct co-investments to HarbourVest Structured Solutions II, L.P, a Guernsey limited partnership managed by HarbourVest Partners LLC. Not reflected in the purchase price were net cash and directly held public equity securities owned by Conversus, which totaled $66.4 million.

Paul, Weiss represented ORIX USA Asset Management in its "Seed & Stake" of New Health Capital Partners (NHCP), a new alternative investment manager founded to make private equity-style investments in health care and life sciences portfolio companies. The investment provides Orix with a unique opportunity to invest in the industry and demonstrates its commitment to the global asset management industry.